Fact CheckerSign in

NCT07426198Completed

The Effect of Oral Care With Propolis in COPD Patients

THE EFFECT OF ORAL CARE WITH PROPOLIS ON THE DEVELOPMENT OF ORAL MUCOSITIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE RECEIVING TREATMENT IN THE INTENSIVE CARE: A RANDOMIZED CONTROLLED TRIAL

Source: ClinicalTrials.gov · Last updated 23 Feb 2026

Brief summary (registry, in English)

The study was conducted in intensive care units and included patients diagnosed with COPD. The study was conducted with a total of 60 COPD patients, 30 in the intervention group and 30 in the control group. Individuals in the intervention group were given an oral care protocol containing propolis for 15 days, in addition to the clinic's standard oral care protocol. The control group continued to receive standard oral care. Oral mucosa was assessed on days 1, 7 and 15.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
16 Feb 2026
Start date
1 Jan 2025
Primary completion date
10 Jun 2025
Lead sponsor
TC Erciyes University
Diseases
COPD
NCT number
NCT07426198

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Jan 2025 to the primary completion date, 10 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • individuals receiving immunosuppressive therapy,
  • individuals receiving mechanical ventilation support,

Other illness

  • individuals with a cancer diagnosis,

Other

  • individuals with altered consciousness or acute confusion,
  • individuals who did not volunteer to participate in the study were excluded from the research.

Who the study is looking for

  • Aged 18 years or older,
  • diagnosed with COPD,
  • no oral mucositis at the start of the study,
  • no known allergy to bees or bee products,
  • able to speak and understand Turkish and communicate effectively,
  • conscious,
  • without any psychiatric illness,
  • without any mental or physical disability that would prevent them from answering questions,
  • individuals who volunteered to participate in the study were included in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Erciyes University
Coordinator of this site? Confirm its status
TalasTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.